RE:sp<p> In my opinion, this could reach all time highs again, once approval is achieved. This can easily be in the $1's ($1-$4)+ if they are able to get that approval.<br /> <br /> Don't forget, this will not only be COVID 19 testing, but demonstrates the company's ability to also use the same methods to do blood samples for cancer detection. As many others have mentioned, this is the perfect "audition period" for the launch of Aristotle. The combination of the covid tests, all of the sentry products, and the launch of Aristotle will have us on that NASDAQ that Tripp was going on about a few quarters ago. GLTA and stay safe. StageZero will change the world for the better, one stage at a time...</p> <p>
DrChristian wrote: <br /> I m looking at 2019 when just the name change increased the sp to 0.20 CAD.<br /> <br /> With FDA and Canada Health approval for Covid test I think sp will go over 0.20 CAD.<br /> <br /> Imo, time will decide. STAY SAFE !
<br /> </p>